Trial intelligence / Profile preview

Carvedilol vs Metoprolol on Endothelial Function

NCT00497003Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Feb 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of carvedilol in chronic heart failure (CHF), type 2 diabetes mellitus (T2DM), sponsored by Bispebjerg and Frederiksberg Hospital. Started Feb 2004; status: completed.

02

Drugs

carvedilol
03

Conditions

chronic heart failure (CHF)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00497003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00497003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call